Standard Uranium Announces C$3,000,000 Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Sept. 30, 2020 […]
Hancock Whitney Corporation to announce third quarter 2020 financial results and host conference call October 20
GULFPORT, Miss., Sept. 30, 2020 (GLOBE NEWSWIRE) — Hancock Whitney Corporation (Nasdaq: HWC) will announce third quarter 2020 financial results […]
TSX News -
Dr. Jack Geltosky Elected to Medicenna Board of Directors
TORONTO and HOUSTON, Sept. 30, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (NASDAQ: MDNA, TSX: MDNA), […]
Hersha Hospitality Trust to Report Third Quarter 2020 Earnings on November 9, 2020
PHILADELPHIA, Sept. 30, 2020 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of high-quality upscale […]
McEwen Mining Appoints Anna Ladd-Kruger as Chief Financial Officer
TORONTO, Sept. 30, 2020 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to announce the appointment of […]
Brookfield Business Partners L.P. 2020 Third Quarter Conference Call and Webcast for Investors and Analysts
Date: Tuesday, November 3, 2020Time: 11:00 a.m. (Eastern Time)BROOKFIELD NEWS, Sept. 30, 2020 (GLOBE NEWSWIRE) — You are invited to […]
Kuuhubb Provides Corporate Update and Announces Closing of US$1.3M Non-Convertible Debenture Financing
TORONTO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Kuuhubb Inc. (“Kuuhubb” or the “Company”)(TSXV: KUU), a mobile game development and publishing […]
CPI Aerostructures Reports First Quarter 2020 Results
First Quarter 2020 vs. Restated First Quarter 2019Revenue of $16.9 million compared to $22.0 million;Gross profit of $0.7 million compared […]
Mercury’s Latest Microwave Tuner Delivers Unparalleled Flexibility and Speed
ANDOVER, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) — Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a leader in trusted, secure mission-critical […]
Selecta Biosciences and Sobi Announce Topline Data of SEL-212 from the Phase 2 COMPARE Trial Supporting the Potential for Important Clinical Improvement in Patients with Chronic Refractory Gout
All data consistent with stronger performance of SEL-212 versus pegloticaseNumerically higher response rate for SEL-212 versus pegloticase during primary endpoint […]
